medtronic cardiovascular organic growth in fiscal 2027

    Above 11%

    medtronic cardiovascular organic growth in fiscal 2027. Best Yes near 25¢ across 1 platform. Live cross-platform prices. Not financial advice.

    Best Yes: 25¢ · Best No: 84¢ · 1 platform

    • Kalshi: Yes 25¢ / No 84¢
    TRADING OPEN

    Above 11%

    Volume

    $0

    $0 24h

    Platforms

    1

    Cross-platform pricing

    Resolution

    Resolves Jun 2, 2027

    ~262 days left

    Category

    Economics

    25¢CHANCE OF YES23%77%
    Yes
    25¢
    Kalshi
    No
    84¢
    Kalshi

    Opens on best-price platform

    Compare & Trade

    1 platform
    kalshi
    Kalshi
    Best Yes
    Best No
    Yes
    25¢
    No
    84¢
    Vol
    $0
    Trade on Kalshi

    Price History

    Loading…

    About This Market

    If Medtronic plc reports Above 11% cardiovascular organic revenue growth in fiscal 2027, then the market resolves to Yes.

    Fee Impact at These Prices

    KalshiKalshiat 25¢: exit costs ~1.31¢/contract
    Full calculator

    Market Details

    ResolutionResolves Jun 2, 2027
    Time Left262 days
    Status● Active
    CategoryEconomics

    Sign in to join the discussion

    Sign In